Jacobson Center for Clinical & Translational Research

Main Menu


Additional Information


Contact Us

Gynecology Research

Study Title:  A Phase 3b Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Combination with Estradiol/ Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women.

Study Purpose:  This phase 3b study seeks to evaluate the safety and efficacy of elagolix in combination with estradiol/ norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.  This study is double-blinded in the first year and an open-label in the second.

Principal Investigator:  Sleiman Smaili, M.D.

Study Coordinator:  Christina Sattler, R.N., 419.383.6225.


Last Updated: 4/4/19